Clinical Trial Update: Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating combination chemotherapy with surgery and radiation, with or without Dexrazoxane and Trastuzumab, for stage III/IV breast cancer was …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Inflammatory Breast Cancer

Drugs mentioned

• DEXRAZOXANE (DEXRAZOXANE)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cardiac Toxicity, Inflammatory Breast Cancer | Phase 3 | Status: TERMINATED